Collectively, these studies suggest that the loss of SirT1 function in post‐stroke muscle is likely due to overactivation of PARP‐1 that could have utilized most of the available intracellular NAD+ needed for SirT1 activity. The gene discussed is SIRT1; the disease is stroke disorder.